We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Johnson Controls International
JCI
$83.8B
| $10.2M | 0.05% |
236,287
-34,940
| -13% | -$1.46M |
|
402
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.78B
| $10M | 0.05% |
90,022
-3,983
| -4% | -$443K |
|
403
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
| $9.99M | 0.05% |
112,980
-4,600
| -4% | -$405K |
|
404
Petrobras Class A
PBR.A
$126B
| $9.98M | 0.05% |
1,337,988
+57,647
| +5% | +$488K |
|
405
Phillips 66
PSX
$106B
| $9.97M | 0.05% |
120,626
-1,054
| -0.9% | -$82.7K |
|
|
UMPQ
406
DELISTED
Umpqua Holdings Corp
UMPQ
| $9.92M | 0.05% |
540,200
-34,000
| -6% | -$603K |
|
407
Hershey
HSY
$34.2B
| $9.9M | 0.04% |
92,200
-6,600
| -7% | -$728K |
|
408
Flowers Foods
FLO
$1.3B
| $9.86M | 0.04% |
569,800
-211,800
| -27% | -$3.98M |
|
|
DNB
409
DELISTED
Dun & Bradstreet
DNB
| $9.85M | 0.04% |
91,118
+100
| +0.1% | +$10.7K |
|
|
XLRN
410
DELISTED
Acceleron Pharma
XLRN
| $9.83M | 0.04% |
+323,555
| New | +$9.38M |
|
411
Deutsche Bank
DB
$72.7B
| $9.82M | 0.04% |
551,872
+189,148
| +52% | +$3.35M |
|
412
McCormick & Company Non-Voting
MKC
$13.4B
| $9.73M | 0.04% |
199,600
-5,200
| -3% | -$263K |
|
413
Robert Half
RHI
$3.92B
| $9.68M | 0.04% |
+201,965
| New | +$9.44M |
|
|
STOR
414
DELISTED
STORE Capital Corporation
STOR
| $9.68M | 0.04% |
431,110
+183,900
| +74% | +$4.07M |
|
415
Planet Fitness
PLNT
$3.84B
| $9.67M | 0.04% |
414,147
-52,000
| -11% | -$1.09M |
|
416
Universal Health Services
UHS
$10.4B
| $9.55M | 0.04% |
78,259
-306
| -0.4% | -$36.4K |
|
417
MetLife
MET
$62.4B
| $9.53M | 0.04% |
194,601
+614
| +0.3% | +$28.5K |
|
418
Ulta Beauty
ULTA
$23.3B
| $9.52M | 0.04% |
33,140
-378
| -1% | -$110K |
|
419
MKS Inc
MKSI
$15.7B
| $9.4M | 0.04% |
+139,700
| New | +$10.6M |
|
420
Supernus Pharmaceuticals
SUPN
$2.4B
| $9.25M | 0.04% |
214,669
+6,399
| +3% | +$228K |
|
421
NetEase
NTES
$76.5B
| $9.2M | 0.04% |
153,055
+149,055
| +3,726% | +$8.55M |
|
422
SL Green Realty
SLG
$3.67B
| $9.18M | 0.04% |
89,653
-300
| -0.3% | -$30.6K |
|
|
LOXO
423
DELISTED
Loxo Oncology, Inc
LOXO
| $9.1M | 0.04% |
113,456
-55,925
| -33% | -$3.1M |
|
424
Henry Schein
HSIC
$9.75B
| $9.07M | 0.04% |
126,439
-2,805
| -2% | -$195K |
|
|
SVC
425
Service Properties Trust
SVC
$861M
| $9.02M | 0.04% |
61,864
-6,539
| -10% | -$998K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.